Continuous intravenous infusion of recombinant human endostatin using infusion pump plus chemotherapy in non-small cell lung cancer

BACKGROUND: Lung cancer is one of the deadliest cancers in the world with the highest incidence and mortality rate among all cancers. Non-small cell lung cancer (NSCLC) accounts for approximately 80% of primary lung cancer. However, efficacy and safety of the current regimens for NSCLC is unsatisfac...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Zhi-Quan, Yang, Si-Fu, Chen, Yun, Hong, Chao-Jin, Zhao, Tong-Wei, Yuan, Guo-Rong, Yang, Liu, Gao, Liang, Wang, Xiao, Lu, Li-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855203/
https://www.ncbi.nlm.nih.gov/pubmed/35211549
http://dx.doi.org/10.12998/wjcc.v10.i4.1164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855203/
https://www.ncbi.nlm.nih.gov/pubmed/35211549
http://dx.doi.org/10.12998/wjcc.v10.i4.1164

Ejemplares similares